InsiderClue
Insiders · Profile

HEGDE SHARATHCHANDRA S

SVP, Research at Theravance Biopharma. Filing since 4 Mar 2019. CIK 0001668696

Company
Date
Role
Action
Shares
Amount
Of holding
TBPH Theravance Biopharma, Inc.
5 Mar 2019
SVP, Research
Sold, plan not stated
5,690
$139.41K
2.1%
TBPH Theravance Biopharma, Inc.
4 Mar 2019
SVP, Research
Sold, plan not stated
3,343
$83.76K
1.2%
2 decisions on file.